Rahat Ul Ain

Dr. Rahat Ul Ain

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in Journal of the College of Physicians and Surgeons Pakistan
Verified
Journal Article
Closed access
RARahat Ul Ain
Rahat Ul Ain
MFMahwish Faizan
Mahwish Faizan
SASaadia Anwar
Saadia Anwar
Objective: To describe the clinical spectrum and outcome-associated variables of pediatric malignant mediastinal masses in a resource-limited setting. Study Design: Descriptive study. Place and Duration of Study: Department of Pediatric Hematology-Oncology, The Children's Hospital, Lahore, from October 2016 to November 2017. Methodology: Children with malignant mediastinal masses were enrolled. The variables studied were median age at presentation, gender distribution, immunisation status, socio-economic background, causes of delayed presentation, presenting complaints, complications of disease, methods for mass biopsy, final diagnosis, staging, and outcome of the disease. Results were described in terms of descriptive statistics. Results: The median age at diagnosis was 7.5 years with male-to-female ratio of 2:1. The commonest presenting complaint was fever (82%), respiratory distress (58%), and lymphadenopathy (51%). Seventy-eight percent patients belonged to lower socio-economic class. Eighty-six percent of patients had delayed presentation to the tertiary care hospital and the most common reason was delayed diagnosis by the medical professionals (49%). Fifty-one percent patients had weight-for-age less than 5th percentile. Common complications were airway obstruction (35%), pericardial effusion (19.6%), superior vena cava syndrome and gross pleural effusion (13.7% each). Commonest diagnosis was T-cell acute lymphoblastic leukemia (35%) followed by lymphoblastic lymphoma and Hodgkin's lymphoma (15.7% each). Fourty-five percent patients expired, 2% defaulted treatment and 5.9% completed treatment; 25% patients were under treatment, 3.9% patients had progressive disease while outcome of 17.6% of patients could not be known. The most significant factor associated with the outcome primary diagnosis (p<0.001), delayed presentation (p=0.007) and educational status of the family. Conclusion: The pattern of clinical presentation, complications and diagnoses of pediatric malignant mediastinal masses showed some variation from the already reported. Low literacy rate and delay in presentation are common and contribute significantly to the poor outcome.

16 December 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
NMNaureen Mushtaq
Naureen Mushtaq
RARahat Ul Ain
Rahat Ul Ain
SHSyed Ahmer Hamid
Syed Ahmer Hamid
EBEric Bouffet
Eric Bouffet
The management of medulloblastoma in children has dramatically changed over the past four decades, with the development of chemotherapy protocols aiming at improving survival and reducing long-term toxicities of high-dose craniospinal radiotherapy. While the staging and treatment of medulloblastoma were until recently based on the modified Chang’s system, recent advances in the molecular biology of medulloblastoma have revolutionized approaches in the management of this increasingly complex disease. The evolution of systemic therapies is described in this review.

26 July 2021 in Journal of the Pakistan Medical Association
Verified
Journal Article
Closed access
RARahat Ul Ain
Rahat Ul Ain
MFMahwish Faizan
Mahwish Faizan
WSWasila Shamim
Wasila Shamim
Objective: To determine the proportion of treatment-related mortality (TRM) among mortalities of Pediatric Acute Lymphoblastic Leukemia (ALL), to identify probable causes and risk factors. Methods: An observational; retrospective, cohort study. Pediatric patients of ALL who expired during treatment were enrolled. Death due to relapse and deaths before treatment were excluded. Retrospective data was collected from ward record and analyzed in SPSS 16. Results: Total 247 patients of ALL expired while 144 patients were enrolled as per inclusion criteria. The proportion of TRM was 58.3%. Median age was 5 years. Male-to-female ratio was 1.3:1. Commonest cause of TRM was sepsis (n=126, 87.5%), followed by hemorrhagic complications (n=11, 7.6%), drug toxicity (n=4, 2.8%), tumor lysis syndrome (n=2, 1.4%) and thromboembolism (n=1, 0.7%). Significant factors associated with TRM were weight-for-age, immunophenotype, reason for admission and absolute neutrophil count. Conclusion: Treatment-related mortality though potentially avoidable is still a major cause of death among pediatric patients of ALL in low-middle income countries. Sepsis is the most common cause and infection prevention and control is vital in improving survival. Best supportive care must be made available for the patients on induction chemotherapy, with concomitant malnutrition, high-risk immunophenotype and profound neutropenia. Continuous...

1 November 2020 in JCO Global Oncology
Verified
Journal Article
Open access
MFMahwish Faizan
Mahwish Faizan
MCMiguela Ayala CANIZA
Miguela Ayala CANIZA
SASaadia Anwar
Saadia Anwar
RARahat Ul Ain
Rahat Ul Ain
RSRabia Saleem
Rabia Saleem
AZAlia Zaidi
Alia Zaidi
PURPOSE: Infection prevention among children with cancer is a major challenge at Children Hospital Lahore (CHL), a public health care facility in Pakistan with 1,000 new pediatric cancer admissions annually. The objective has been to reduce infections through collaboration between CHL and the St Jude Children’s Hospital Global Infectious Disease program via a grant by the Sanofi Espoir foundation through the My Child Matters program. The aim of the current study was to describe the effect of the collaborative improvement strategy on existing infection prevention and control (IPC) standards at CHL. MATERIALS AND METHODS: Our work was a prospective before-and-after study to improve IPC standards. We compared the WHO Hand Hygiene Self-Assessment Framework and four modules of the St Jude modified Infection Control Assessment Tool (ICAT) scores over a 3-year period. Our strategy included creating a multidisciplinary team of pediatric oncologists, infectious disease physicians, nurses, a microbiologist, and a data manager; engaging in monthly online IPC mentoring sessions with St Jude Children’s Hospital Global Infectious Disease program and My Child Matters mentors; performing daily inpatient health care–associated infection surveillance rounds; and performing regular hand hygiene training and compliance audits. RESULTS: Baseline needs assessment showed health care–associated infections identified by positive blood cultures as 8.7 infections per 1,000 patient-days. Deficient hand hygiene supplies, health education measures, and bed sharing of neutropenic patients were identified as major challenges. Our hand hygiene facility level, per WHO scores, increased from Inadequate to Intermediate/Consolidation by the end of the 3-year implementation (122 v 352 WHO Hand Hygiene Self-Assessment Framework scores). The sink:bed and hand sanitizer:bed ratios improved to 1:6 and 1:1, respectively. The ICAT general infection control module increased by 40% (45 v 78 ICAT scores) and hygiene compliance improved by 20%. CONCLUSION: Implementing a collaborative improvement strategy improved IPC standards in our center, which can be easily replicated in other pediatric oncology centers in lower- and middle-income countries.

2 May 2025 in Pakistan Journal of Medical Sciences
Verified
Journal Article
Open access
PDF file
RARahat Ul Ain
Rahat Ul Ain
ARAli Abdur Rahman
Ali Abdur Rahman
ATAsfand Tariq
Asfand Tariq
MFMahwish Faizan
Mahwish Faizan
Background & Objectives: Pediatric cancers have a huge survival gap between the high-income and the low-middle-income countries (LMICs). Despite various other causes, the advanced stage of presentation is a major contributing factor but limited data is available from developing countries in this regard. This study aimed to identify delay in treatment and factors associated with it in our setup. Methods: This was a Cross-Sectional survey conducted at the department of pediatric hematology-oncology Children Hospital Lahore using a questionnaire-based interview of parents of all newly diagnosed cases of pediatric cancers presenting to Pakistan’s largest public-sector specialized center at the Children’s Hospital Lahore, over two months, i.e. from December 1, 2023 to January 31, 2024. The data was analyzed using SPSS version 23.0. Results: A total of 119 new patients presenting to the hospital were included. The median total delay in treatment of children with cancer was 63 days which is less than comparable LMICs, but physician and healthcare system delay that makes up the major portion of the total delay is equivalent to some low-income countries. The patient delay was negligible. The statistically significant factors associated with delay were gender, age of the patient; and type of cancer. Whereas, the distance from the specialized center and the socio-economic status of the family did not contribute significantly. Conclusions: Healthcare system delay is a major contributor therefore strengthening the existing medical services, development of medical referral systems, and medical professional awareness and education can improve delays in treatment and outcomes in our setup. doi: https://doi.org/10.12669/pjms.41.5.9663 How to cite this: Rahat Ul Ain, Rahman AA, Tariq A, Faizan M. Delay in diagnosis and treatment of childhood cancers in a developing country: A cross-sectional patient-based survey at country’s largest pediatric oncology center. Pak J Med Sci. 2025;41(5):1267-1273. doi: https://doi.org/10.12669/pjms.41.5.9663 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

13 April 2022 in ecancermedicalscience
Verified
Journal Article
Open access
RARahat Ul Ain
Rahat Ul Ain
MFMahwish Faizan
Mahwish Faizan
SASaadia Anwar
Saadia Anwar
SRShazia Riaz
Shazia Riaz
AAAlia Ahmad
Alia Ahmad
WSWasila Shamim
Wasila Shamim
Acute leukaemia in children with Down syndrome in a low middle-income country Rahat Ul-Aina, Mahwish Faizan, Saadia Anwar, Shazia Riaz, Alia Ahmad, Huma Zafa